Filter
278
Filtered Results: 278
Text search:
molecular
markers
Featured
Recommendations
36
New Publications
55
Language
Document type
No document type
130
Guidelines
66
Studies & Reports
45
Manuals
17
Fact sheets
9
Training Material
4
Strategic & Response Plan
4
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
34
Global
14
Africa
9
Kenya
8
Latin America and the Carribbean
7
South Africa
4
Tanzania
3
Brazil
3
West and Central Africa
3
Sierra Leone
2
Congo, Democratic Republic of
2
USA
2
Cameroon
2
Uganda
2
Philippines
2
Pakistan
2
Benin
2
Venezuela
2
Guinea
1
Liberia
1
Nigeria
1
Côte d’Ivoire / Ivory Coast
1
Ethiopia
1
Zimbabwe
1
Nepal
1
Afghanistan
1
Zambia
1
Syria
1
Chad
1
Malawi
1
Peru
1
Angola
1
East and Southern Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
71
Clinical Guidelines
59
Public Health
24
Pharmacy & Technologies
14
Key Resources
5
Women & Child Health
4
Capacity Building
3
Toolboxes
COVID-19
35
TB
29
HIV
20
Mental Health
19
NTDs
18
AMR
17
NCDs
14
Rapid Response
12
Ebola
6
Pharmacy
5
Refugee
4
Planetary Health
3
Disability
2
Cholera
2
Specific Hazards
2
Polio
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and ... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and mo... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecu... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and ... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecul... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and ... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and ... markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular...
Full document available: https://www.icmr.nic.in/sites/default/files/guidelines/Gastric%20Cancer%20Final%20pdf%20for%20farrow_0.pdf | Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Gastri...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different ... mechanisms underlying Trypanosoma cruzi’s infection and the host-parasite interactions that follow, prompt diagnosis and treatment remain a challenge, particu-larly in developing countries and also in those where the disease is considered non-endemic. This review intends to present an up-to-date review of the parasite’s life cycle, genetic diversity, virulence factors, and infective mechanisms, as well as the epidemiology, clinical presentation, diagnosis, and treatment options of the main chronic complications of Chagas disease.
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying ... and mortality risk factors in critically ill patients, as well as infection control, sample collection, supportive care (respiratory and hemodynamic), pharmacological treatment, early rehabilitation, diagnostic imaging use, prevention of complications, and discharge requirements. The recommendations are for all health care staff caring for patients in emergency departments and ICUs. These guidelines are also intended for use by decisionmakers and government entities involved in the management of patients with COVID-19 in ICUs in the Region of the Americas.
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
